Eli Lilly

UnitedHealth Group

Johnson & Johnson

Merck

AbbVie

Thermo Fisher Scientific

Abbott Labs

Amgen

Danaher

Pfizer

ProShares Ultra Health Care

RXL provides 2x leveraged exposure to a cap-weighted index of US health care companies.

ProShares Ultra Oil & Gas

ProShares Ultra Technology

ProShares Ultra Consumer Goods

ProShares Ultra Financials

With a new year comes the opportunity to make changes, and that's what ProShares has done by swapping benchmarks on 23 ETFs, largely focused on their inverse and leveraged strategies.

ProShares Makes Benchmark Changes to 23 ETFs

ProShares UltraShort Oil & Gas

ProShares Ultra Telecommunications

ProShares Short Real Estate

ProShares UltraShort Technology

ProShares UltraShort Health Care

ProShares UltraShort Consumer Discretionary 

ProShares UltraShort Utilities

ProShares Short Financials

ProShares UltraShort Industrials

ProShares UltraShort Financials

ProShares UltraShort Basic Materials

ProShares UltraShort Real Estate

ProShares UltraShort Consumer Goods

ProShares Ultra Consumer Services

ProShares Ultra Utilities

ProShares Ultra Real Estate

ProShares Ultra Industrials

ProShares Ultra Basic Materials

BETHESDA, Md.--( BUSINESS WIRE )--ProShares and ProFunds, premier providers of leveraged and inverse funds, announced plans to change the underlying indices for a combined 53 sector ETFs and mutual funds to S&P Select Indices.

ProShares and ProFunds Announce Benchmark Changes for 53 Geared Sector Funds

VanEck Vectors Biotech ETF

Virtus LifeSci Biotech Products ETF

Principal Healthcare Innovators Index ETF

Loncar Cancer Immunotherapy ETF

Direxion Daily Healthcare Bull 3x Shares

First Trust NYSE Arca Biotechnology Index Fund

Fidelity MSCI Health Care ETF

First Trust Nasdaq Pharmaceuticals ETF 

First Trust Health Care AlphaDEX Fund

Amplify Treatments Testing & Advancements ETF

Global X Genomics & Biotechnology ETF

abrdn Healthcare Investors 

abrdn Life Sciences Investors 

iShares Nasdaq Biotechnology ETF

Defiance Nasdaq Junior Biotechnology ETF

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare ETF

John Hancock Multifactor Healthcare ETF

Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

Global X Longevity Thematic ETF

Invesco Dynamic Biotechnology & Genome ETF

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Invesco Dynamic Pharmaceuticals ETF

VanEck Vectors Pharmaceutical ETF

Invesco S&P 500 Equal Weight Health Care ETF

Vanguard Health Care ETF

Pacer BioThreat ETF

SPDR S&P Biotech ETF

Health Care Select Sector SPDR Fund

SPDR S&P Pharmaceuticals ETF

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of this year, as operations that were disrupted return to normal.

Biotech Innovations Remain At Forefront

LeMaitre Vascular

The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets.

Healthcare: A Wide Choice Of Large And Well-Established Companies

ProShares UltraShort MidCap400

ProShares UltraShort QQQ

ProShares UltraShort SmallCap600

ProShares UltraPro Short MidCap400

ProShares UltraPro Short S&P500

ProShares UltraPro Short Russell2000

ProShares UltraPro QQQ

ProShares UltraShort Russell2000

The issuers were among a number of firms making changes to expense ratios and enacting splits.

ProShares, First Trust Make Changes To ETFs

RXL Is The Best Healthcare ETF Wealth-Builder Now

News for ProShares Ultra Health Care ETF (RXL)